Reagents used in conjunction with the MobiNova-D1.The tumor dissociation kit is developed for the dissociation of primary human tumors and xenografts. It has been optimized for a variety of tumor types, including breast cancer, pancreatic cancer, prostate cancer, colon cancer, lung adenocarcinoma, etc.